chr9-128908178-T-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_019594.4(LRRC8A):​c.1014T>C​(p.Tyr338Tyr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.195 in 1,613,768 control chromosomes in the GnomAD database, including 33,853 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.24 ( 5162 hom., cov: 31)
Exomes 𝑓: 0.19 ( 28691 hom. )

Consequence

LRRC8A
NM_019594.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 2.78

Publications

24 publications found
Variant links:
Genes affected
LRRC8A (HGNC:19027): (leucine rich repeat containing 8 VRAC subunit A) This gene encodes a protein belonging to the leucine-rich repeat family of proteins, which are involved in diverse biological processes, including cell adhesion, cellular trafficking, and hormone-receptor interactions. This family member is a putative four-pass transmembrane protein that plays a role in B cell development. Defects in this gene cause autosomal dominant non-Bruton type agammaglobulinemia, an immunodeficiency disease resulting from defects in B cell maturation. Multiple alternatively spliced transcript variants, which encode the same protein, have been identified for this gene. [provided by RefSeq, Jul 2008]
LRRC8A Gene-Disease associations (from GenCC):
  • autosomal agammaglobulinemia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • agammaglobulinemia 5, autosomal dominant
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.63).
BP6
Variant 9-128908178-T-C is Benign according to our data. Variant chr9-128908178-T-C is described in ClinVar as Benign. ClinVar VariationId is 403060.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.78 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.394 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LRRC8ANM_019594.4 linkc.1014T>C p.Tyr338Tyr synonymous_variant Exon 3 of 4 ENST00000372600.9 NP_062540.2 Q8IWT6A0A024R892

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LRRC8AENST00000372600.9 linkc.1014T>C p.Tyr338Tyr synonymous_variant Exon 3 of 4 1 NM_019594.4 ENSP00000361682.4 Q8IWT6
LRRC8AENST00000372599.7 linkc.1014T>C p.Tyr338Tyr synonymous_variant Exon 2 of 3 1 ENSP00000361680.3 Q8IWT6
LRRC8AENST00000259324.5 linkc.1014T>C p.Tyr338Tyr synonymous_variant Exon 3 of 4 2 ENSP00000259324.5 Q8IWT6

Frequencies

GnomAD3 genomes
AF:
0.239
AC:
36369
AN:
151884
Hom.:
5158
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.399
Gnomad AMI
AF:
0.132
Gnomad AMR
AF:
0.168
Gnomad ASJ
AF:
0.193
Gnomad EAS
AF:
0.192
Gnomad SAS
AF:
0.290
Gnomad FIN
AF:
0.126
Gnomad MID
AF:
0.288
Gnomad NFE
AF:
0.179
Gnomad OTH
AF:
0.251
GnomAD2 exomes
AF:
0.197
AC:
49560
AN:
251302
AF XY:
0.201
show subpopulations
Gnomad AFR exome
AF:
0.409
Gnomad AMR exome
AF:
0.122
Gnomad ASJ exome
AF:
0.206
Gnomad EAS exome
AF:
0.170
Gnomad FIN exome
AF:
0.127
Gnomad NFE exome
AF:
0.182
Gnomad OTH exome
AF:
0.203
GnomAD4 exome
AF:
0.191
AC:
278756
AN:
1461766
Hom.:
28691
Cov.:
35
AF XY:
0.194
AC XY:
140740
AN XY:
727170
show subpopulations
African (AFR)
AF:
0.413
AC:
13836
AN:
33480
American (AMR)
AF:
0.129
AC:
5750
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.205
AC:
5346
AN:
26136
East Asian (EAS)
AF:
0.212
AC:
8428
AN:
39700
South Asian (SAS)
AF:
0.288
AC:
24824
AN:
86258
European-Finnish (FIN)
AF:
0.124
AC:
6627
AN:
53306
Middle Eastern (MID)
AF:
0.279
AC:
1607
AN:
5768
European-Non Finnish (NFE)
AF:
0.180
AC:
199844
AN:
1111998
Other (OTH)
AF:
0.207
AC:
12494
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
16674
33348
50021
66695
83369
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
7192
14384
21576
28768
35960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.239
AC:
36395
AN:
152002
Hom.:
5162
Cov.:
31
AF XY:
0.237
AC XY:
17606
AN XY:
74278
show subpopulations
African (AFR)
AF:
0.399
AC:
16543
AN:
41418
American (AMR)
AF:
0.167
AC:
2554
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.193
AC:
670
AN:
3470
East Asian (EAS)
AF:
0.191
AC:
986
AN:
5162
South Asian (SAS)
AF:
0.290
AC:
1392
AN:
4800
European-Finnish (FIN)
AF:
0.126
AC:
1337
AN:
10590
Middle Eastern (MID)
AF:
0.286
AC:
84
AN:
294
European-Non Finnish (NFE)
AF:
0.179
AC:
12187
AN:
67980
Other (OTH)
AF:
0.248
AC:
522
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1311
2622
3932
5243
6554
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
378
756
1134
1512
1890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.203
Hom.:
8600
Bravo
AF:
0.249
Asia WGS
AF:
0.201
AC:
697
AN:
3478
EpiCase
AF:
0.191
EpiControl
AF:
0.200

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Agammaglobulinemia 5, autosomal dominant Benign:1
Aug 19, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.63
CADD
Benign
8.9
DANN
Benign
0.43
PhyloP100
2.8
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3750320; hg19: chr9-131670457; COSMIC: COSV52185470; COSMIC: COSV52185470; API